Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Oomen, Ilja"'
Autor:
Oomen, Ilja, Abdi, Amal, Camelo, Ricardo M., Callado, Fábia M.R.A., Carvalho, Luany E.M., Calcaterra, Ilenia L., Carcao, Manuel, Castaman, Giancarlo, Eikenboom, Jeroen C.J., Fischer, Kathelijn, Franco, Vivian K.B., Heymans, Martijn W., Leebeek, Frank W.G., Lillicrap, David, Lorenzato, Cláudia S., Mancuso, Maria Elisa, Matino, Davide, Di Minno, Matteo N.D., Mohseny, Alex B., Oldenburg, Johannes, Rezende, Suely Meireles, Rivard, Georges-Etienne, Rydz, Natalia, Schols, Saskia E.M., Voorberg, Jan, Fijnvandraat, Karin, Gouw, Samantha C.
Publikováno v:
In Research and Practice in Thrombosis and Haemostasis October 2024 8(7)
Autor:
Oomen, Ilja, Camelo, Ricardo M., Rezende, Suely Meireles, Voorberg, Jan, Mancuso, Maria Elisa, Oldenburg, Johannes, Carcao, Manuel, Matino, Davide, Lillicrap, David, Fischer, Kathelijn, Fijnvandraat, Karin, Gouw, Samantha C.
Publikováno v:
In Research and Practice in Thrombosis and Haemostasis January 2023 7(1)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Oomen, Ilja, Rashid, Amara Nassar-Sheikh, Bouts, Antonia H. M., Gouw, Samantha C., Kuijpers, Taco W., Rispens, Theo, de Vries, Annick, Wolbink, Gertjan, van den Berg, J. Merlijn, Schonenberg-Meinema, Dieneke
Publikováno v:
Clinical and experimental rheumatology, 39(5), 183-190. Clinical and Experimental Rheumatology S.A.S.
Clinical and Experimental Rheumatology, 40(1), 183-190. Clinical and Experimental Rheumatology S.A.S.
Clinical and Experimental Rheumatology, 39(5), 183-190. Clinical and Experimental Rheumatology S.A.S.
Oomen, I, Rashid, A N-S, Bouts, A H M, Gouw, S C, Kuijpers, T W, Rispens, T, de Vries, A, Wolbink, G, van den Berg, J M & Schonenberg-Meinema, D 2021, ' Anti-rituximab antibodies affect pharmacokinetics and pharmacodynamics of rituximab in children with immune-mediated diseases ', Clinical and Experimental Rheumatology, vol. 39, no. 5, pp. 183-190 . https://doi.org/10.55563/CLINEXPRHEUMATOL/FTIRA8
Clinical and Experimental Rheumatology, 40(1), 183-190. Clinical and Experimental Rheumatology S.A.S.
Clinical and Experimental Rheumatology, 39(5), 183-190. Clinical and Experimental Rheumatology S.A.S.
Oomen, I, Rashid, A N-S, Bouts, A H M, Gouw, S C, Kuijpers, T W, Rispens, T, de Vries, A, Wolbink, G, van den Berg, J M & Schonenberg-Meinema, D 2021, ' Anti-rituximab antibodies affect pharmacokinetics and pharmacodynamics of rituximab in children with immune-mediated diseases ', Clinical and Experimental Rheumatology, vol. 39, no. 5, pp. 183-190 . https://doi.org/10.55563/CLINEXPRHEUMATOL/FTIRA8
Objective Rituximab (RTX) is a chimeric monoclonal CD20-antibody. Lack of efficacy has been suggested to be related to the presence of anti-drug antibodies (ADA). The aims of this study were to determine if ADA impact the pharmacokinetics (PK) and ph
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Oomen I; Amsterdam University Medical Center location University of Amsterdam, Department of Pediatric Hematology, Meibergdreef 9, Amsterdam, The Netherlands.; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands., Camelo RM; Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands., Rezende SM; Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Voorberg J; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands., Mancuso ME; Center for Thrombosis and Hemorrhagic Diseases, Instituto di Ricovero e Cura a Carattere Scientifico Humanitas Research Hospital, Rozzano, Milan, Italy., Oldenburg J; Department of Internal Medicine, University Clinic Bonn, University of Bonn, Bonn, Germany., Carcao M; Division of Hematology/Oncology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada., Matino D; Department of Medicine, McMaster University, University of Hamilton, Hamilton, Canada., Lillicrap D; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., Fischer K; Department of Hematology, Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands., Fijnvandraat K; Amsterdam University Medical Center location University of Amsterdam, Department of Pediatric Hematology, Meibergdreef 9, Amsterdam, The Netherlands.; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands., Gouw SC; Amsterdam University Medical Center location University of Amsterdam, Department of Pediatric Hematology, Meibergdreef 9, Amsterdam, The Netherlands.; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2022 Dec 20; Vol. 7 (1), pp. 100020. Date of Electronic Publication: 2022 Dec 20 (Print Publication: 2023).